Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory Concentration
Condition(s):Aminoglycoside Dosing Based on PK/PD CharacteristicsLast Updated:March 1, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Aminoglycoside Dosing Based on PK/PD CharacteristicsLast Updated:March 1, 2024Recruiting
Condition(s):Cystic Fibrosis; Cystic Fibrosis Pulmonary ExacerbationLast Updated:September 13, 2023Recruiting
Condition(s):Urinary Tract Infections; Recurrent Urinary Tract InfectionLast Updated:March 8, 2023Completed
Condition(s):Underdosing of Aminoglycosides; Critical IllnessLast Updated:January 24, 2019Completed
Condition(s):Infection; Renal DysfunctionLast Updated:February 2, 2016Completed
Condition(s):Aminoglycoside Toxicity; Acute Kidney InjuryLast Updated:November 18, 2023Completed
Condition(s):Acute Kidney Injury; Severe SepsisLast Updated:August 30, 2013Completed
Condition(s):Sepsis; Septic Shock; Aminoglycoside Toxicity; Renal Replacement TherapyLast Updated:January 26, 2024Recruiting
Condition(s):Sepsis; Septic Shock; Hematologic Malignancy; Tumor; Allogeneic Stem Cell TransplantationLast Updated:July 5, 2022Not yet recruiting
Condition(s):Urinary Tract Infections; Urological System Complication of ProcedureLast Updated:February 8, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.